Literature DB >> 2315284

The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica.

P J Skuce1, I Fairweather.   

Abstract

The present study describes the effects of the H+ ionophore and anthelmintic closantel upon the in vitro motility and in vivo ultrastructure of the liver fluke, Fasciola hepatica. At a concentration of 50 micrograms/ml, closantel caused an initial stimulation, then suppression of activity, which was accompanied by an increase in muscle tone and led to a spastic paralysis within 2 h. The pattern of response was similar at lower concentrations, although the initial stimulation was not always evident, but the onset of paralysis could be reached more quickly. Scanning electron microscopy revealed gross surface damage from 24 h onwards in vivo, in the form of erosion of the anterior and posterior extremities of the fluke and large-scale sloughing of the tegument on both dorsal and ventral surfaces. Tegumental changes prior to sloughing included some swelling of the basal infolds and an apical accumulation of T1 secretory bodies. In the underlying tegumental cells there was reduced secretory activity and the mitochondria were consistently swollen and deformed. Reduced secretory activity was a feature of the gastrodermal cells as well; these cells were characterized by swollen, electron-lucent mitochondria, vesiculated GER cisternae and apical blebbing of packets of cytoplasm. The vitelline follicles became severely disrupted as a result of the breakdown of the nurse cell cytoplasm. The stem and intermediate type 1 (It1) cells rounded up and showed nuclear abnormalities. There did not appear to be a severe disruption of shell protein production in the intermediate vitelline cells, but there was a noticeable absence of glycogen in the mature vitelline cells. The effects of closantel are discussed in relation to its proposed mode of action as an uncoupler of oxidative phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315284     DOI: 10.1007/BF00930821

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  40 in total

1.  Mechanism of uncoupling in mitochondria: uncouplers as ionophores for cycling cations and protons.

Authors:  R J Kessler; C A Tyson; D E Green
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

2.  Fasciola hepatica: effect of 4-amino-6-trichloroethenyl-1,3-benzenedisulfonamide on glycolysis in vitro.

Authors:  M D Schulman; D Valentino
Journal:  Exp Parasitol       Date:  1980-04       Impact factor: 2.011

3.  Changes in energy metabolism due to anthelmintics in Fasciola hepatica maintained in vitro.

Authors:  R A Cornish; C Bryant
Journal:  Int J Parasitol       Date:  1976-10       Impact factor: 3.981

4.  Closantel, a new antiparasitic hydrogen ionophore [proceedings].

Authors:  H Van Den Bossche; H Verhoeven; O Vanparijs; H Lauwers; D Thienpont
Journal:  Arch Int Physiol Biochim       Date:  1979-10

5.  Fasciola hepatica: the effect of the sodium ionophore monensin on the adult tegument.

Authors:  P J Skuce; I Fairweather
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

6.  Fasciola hepatica: perturbation of secretory activity in the vitelline cells by the sodium ionophore monensin.

Authors:  P J Skuce; I Fairweather
Journal:  Exp Parasitol       Date:  1988-02       Impact factor: 2.011

7.  The biochemical mode of action of the fasciolicides nitroxynil, hexachlorophane and oxyclozanide.

Authors:  J R Corbett; A J Goose
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

8.  Fasciola hepatica: tegumental alterations as a consequence of lectin binding.

Authors:  M T Rogan; L T Threadgold
Journal:  Exp Parasitol       Date:  1984-06       Impact factor: 2.011

9.  Fasciola hepatica: the effects of neuropharmacological agents upon in vitro motility.

Authors:  S D Holmes; I Fairweather
Journal:  Exp Parasitol       Date:  1984-10       Impact factor: 2.011

10.  Diamphenethide--a reassessment of its pharmacological action.

Authors:  I Fairweather; P J Skuce; S D Holmes
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

View more
  18 in total

1.  Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax).

Authors:  B McKinstry; I Fairweather; G P Brennan; A B Forbes
Journal:  Parasitol Res       Date:  2003-08-22       Impact factor: 2.289

2.  Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes.

Authors:  M Meaney; I Fairweather; G P Brennan; L S L McDowell; A B Forbes
Journal:  Parasitol Res       Date:  2003-08-22       Impact factor: 2.289

3.  Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.

Authors:  Catherine Devine; Gerard P Brennan; Carlos E Lanusse; Luis I Alvarez; Alan Trudgett; Elizabeth Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2010-03-25       Impact factor: 2.289

4.  Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).

Authors:  B McKinstry; G P Brennan; L Halferty; A B Forbes; I Fairweather
Journal:  Parasitol Res       Date:  2007-06-08       Impact factor: 2.289

5.  Fasciola hepatica: the effect of the microfilament inhibitor cytochalasin B on the ultrastructure of the adult fluke.

Authors:  A W Stitt; I Fairweather
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

6.  Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.

Authors:  M McConville; G P Brennan; A Flanagan; R E B Hanna; H W J Edgar; R Castillo; A Hernández-Campos; I Fairweather
Journal:  Parasitol Res       Date:  2009-05-21       Impact factor: 2.289

7.  The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica.

Authors:  P J Skuce; I Fairweather
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

8.  Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.

Authors:  C Devine; G P Brennan; C E Lanusse; L I Alvarez; A Trudgett; E Hoey; I Fairweather
Journal:  Parasitol Res       Date:  2011-03-26       Impact factor: 2.289

9.  Repositioning of an existing drug for the neglected tropical disease Onchocerciasis.

Authors:  Christian Gloeckner; Amanda L Garner; Fana Mersha; Yelena Oksov; Nancy Tricoche; Lisa M Eubanks; Sara Lustigman; Gunnar F Kaufmann; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

10.  Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

Authors:  A W Stitt; I Fairweather
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.